olprinone has been researched along with Angina Pectoris in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, T; Enomoto, Y; Inoue, H; Kuno, Y; Okuda, Y | 1 |
| Morioka, S; Murakami, R; Murakami, Y; Sano, K; Shimada, T | 1 |
2 other study(ies) available for olprinone and Angina Pectoris
| Article | Year |
|---|---|
[Anesthetic management of coronary artery bypass grafting for unstable angina pectoris in a patient undergoing home oxygen therapy].
Topics: Aged; Anesthesia; Angina Pectoris; Cardiac Output, Low; Coronary Artery Bypass, Off-Pump; Emergencies; Humans; Imidazoles; Infusions, Intravenous; Intraoperative Complications; Male; Oxygen Inhalation Therapy; Perioperative Care; Pneumoconiosis; Pyridones; Treatment Outcome | 2008 |
Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochloride), on cardiac function: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship.
Topics: Aged; Angina Pectoris; Cardiac Catheterization; Cardiac Volume; Cardiotonic Agents; Coronary Angiography; Coronary Circulation; Coronary Disease; Coronary Vasospasm; Coronary Vessels; Diastole; Female; Heart; Heart Rate; Humans; Hypertension; Imidazoles; Injections; Male; Middle Aged; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Stroke Volume; Systole; Ventricular Function, Left; Ventricular Pressure | 1995 |